Literature DB >> 23587840

Screening for impaired fasting glucose and diabetes using available health plan data.

Laura N McEwen1, Sara R Adams, Julie A Schmittdiel, Assiamira Ferrara, Joseph V Selby, William H Herman.   

Abstract

AIMS: To develop and validate prediction equations to identify individuals at high risk for type 2 diabetes using existing health plan data.
METHODS: Health plan data from 2005 to 2009 from 18,527 members of a Midwestern HMO without diabetes, 6% of whom had fasting plasma glucose (FPG) ≥110mg/dL, and health plan data from 2005 to 2006 from 368,025 members of a West Coast-integrated delivery system without diabetes, 13% of whom had FPG ≥110mg/dL were analyzed. Within each health plan, we used multiple logistic regression to develop equations to predict FPG ≥110mg/dL for half of the population and validated the equations using the other half. We then externally validated the equations in the other health plan.
RESULTS: Areas under the curve for the most parsimonious equations were 0.665 to 0.729 when validated internally. Positive predictive values were 14% to 32% when validated internally and 14% to 29% when validated externally.
CONCLUSION: Multivariate logistic regression equations can be applied to existing health plan data to efficiently identify persons at higher risk for dysglycemia who might benefit from definitive diagnostic testing and interventions to prevent or treat diabetes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Administrative data; Diabetes; Impaired fasting glucose; Screening

Mesh:

Substances:

Year:  2013        PMID: 23587840      PMCID: PMC3714351          DOI: 10.1016/j.jdiacomp.2013.01.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  16 in total

1.  A multivariate logistic regression equation to screen for diabetes: development and validation.

Authors:  Bahman P Tabaei; William H Herman
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

2.  A multivariate logistic regression equation to screen for dysglycaemia: development and validation.

Authors:  B P Tabaei; M M Engelgau; W H Herman
Journal:  Diabet Med       Date:  2005-05       Impact factor: 4.359

3.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Eberhard Standl; Małgorzata Bartnik; Greet Van den Berghe; John Betteridge; Menko-Jan de Boer; Francesco Cosentino; Bengt Jönsson; Markku Laakso; Klas Malmberg; Silvia Priori; Jan Ostergren; Jaakko Tuomilehto; Inga Thrainsdottir; Ilse Vanhorebeek; Marco Stramba-Badiale; Peter Lindgren; Qing Qiao; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; John Camm; Veronica Dean; Jaap Deckers; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; Juan Tamargo; José Luis Zamorano; Jaap W Deckers; Michel Bertrand; Bernard Charbonnel; Erland Erdmann; Ele Ferrannini; Allan Flyvbjerg; Helmut Gohlke; Jose Ramon Gonzalez Juanatey; Ian Graham; Pedro Filipe Monteiro; Klaus Parhofer; Kalevi Pyörälä; Itamar Raz; Guntram Schernthaner; Massimo Volpe; David Wood
Journal:  Eur Heart J       Date:  2007-01       Impact factor: 29.983

4.  Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

Authors:  H C Gerstein; S Yusuf; J Bosch; J Pogue; P Sheridan; N Dinccag; M Hanefeld; B Hoogwerf; M Laakso; V Mohan; J Shaw; B Zinman; R R Holman
Journal:  Lancet       Date:  2006-09-23       Impact factor: 79.321

5.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

6.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

7.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

8.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

9.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

10.  The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS.

Authors: 
Journal:  Diabetes Care       Date:  2012-04       Impact factor: 19.112

View more
  6 in total

Review 1.  The global agenda for the prevention of type 2 diabetes.

Authors:  William H Herman
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

Review 2.  Status Update on Translation of Integrated Primary Dental-Medical Care Delivery for Management of Diabetic Patients.

Authors:  Ingrid Glurich; Gregory Nycz; Amit Acharya
Journal:  Clin Med Res       Date:  2017-04-03

Review 3.  Review of Metformin Use for Type 2 Diabetes Prevention.

Authors:  Tannaz Moin; Julie A Schmittdiel; James H Flory; Jessica Yeh; Andrew J Karter; Lydia E Kruge; Dean Schillinger; Carol M Mangione; William H Herman; Elizabeth A Walker
Journal:  Am J Prev Med       Date:  2018-08-17       Impact factor: 6.604

4.  Screening for prediabetes and type 2 diabetes in dental offices.

Authors:  William H Herman; George W Taylor; Jed J Jacobson; Ray Burke; Morton B Brown
Journal:  J Public Health Dent       Date:  2015-02-06       Impact factor: 1.821

5.  Use of metformin following a population-level intervention to encourage people with pre-diabetes to enroll in the National Diabetes Prevention Program.

Authors:  Thomas E Hurst; Laura N McEwen; Kevin L Joiner; William H Herman
Journal:  BMJ Open Diabetes Res Care       Date:  2021-10

6.  The Effectiveness of a Proactive, Three-Level Strategy to Identify People With Prediabetes in a Large Workforce With Employer-Sponsored Health Insurance.

Authors:  William H Herman; Kevin Joiner; Thomas Hurst; Laura N McEwen
Journal:  Diabetes Care       Date:  2021-05-20       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.